Human Hematopoietic‐Myeloid Leukemia Cell Line (AML14.3D10)

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Tumor Cells

Tissue Type

Peripheral Blood

Organism

Human (H. sapiens)

Donor History

Male

,

68

,

FAB M2 Acute Myeloid Leukemia

Growth Properties

Suspension

,

Proliferates as an eosinophilic myelocyte to met amyelocyte

,

containing eosinophil secondary granules

Growth Conditions

PriCoat™ T25 Flasks (G299) are recommended for optimal cell culture. PriGrow II (TM002) + 8% FBS + 2mM L-glutamine (G275) + 1mM Sodium Pyruvate (TM057) + 50uM Beta- mercaptoethanol + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂. Note: Cells are difficult to recover from freeze-thaw conditions and typically show 20-30% viability post-thaw; allow cells to recover in the first 72 hours through frequent media changes. It is absolutely imperative to perform a cell viabilty count each time cells are passaged  to keep them between 3 x 105 – 1 x 106 maximum/ml. Do not allow the cells to achieve a density greater than 8 X 105 viable cells/ml.; this will lead to terminal differentiation and cell death. Addition of 100 pg/ml GM-CSF to the culture media during the first week post-thaw will allow for more rapid recovery and improved cell viability. 

Immortalization Method

Tumor Cell Line

Full Information

https://www.abmgood.com/human-hematopoieticmyeloid-leukemia-cell-line-aml143d10-t8172.html

Katalogové číslo: T8172 Kategorie: ,
Popis

The AML14.3D10 cell line is the fully differentiated eosinophilic subline of the AML14 (Cat. T8171) cell line. These cells maintain an eosinophilic phenotype and proliferate without the addition of exogenous cytokines. AML14.3D10 proliferates rapidly in response to GM-CSF and IL-5 and expresses the α‐subunit of the IL‐3 receptor.Parental cell line:Cat. T8171 – Human Hematopoietic‐Myeloid Leukemia Cell Line (AML14)

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.